Skip to content

3i T3® DCD® BNSS313Recalls & reported problems

ZimVie US Corp LLC · 3i T3® WITH DCD® NON-PLATFORM SWITCHED PARALLEL WALLED IMPLANT 3.25 X 13MM · Class 2 · Implant

All models of 3i T3 DCD (73)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00844868028994), received between Oct 6, 2022 and Oct 6, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Separation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Separation Failure1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 6, 2022Separation Failure; Separation Failure

    IT WAS REPORTED THAT DRIVER TIP DID NOT DISENGAGE FROM THE IMPLANT. PROCEDURE HAS BEEN COMPLETED USING ANOTHER DEVICE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15553335 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page